The interaction of hexafluorenium with other neuromuscular blocking agents in man.
D002800:Cholinesterase Inhibitors; D003650:Decamethonium Compounds / Q000494:pharmacology*; D004357:Drug Synergism; D004576:Electromyography; D005703:Gallamine Triethiodide / Q000494:pharmacology*; D005730:Ganglionic Blockers / Q000494:pharmacology*; D006801:Humans; D007275:Injections, Intravenous; D009132:Muscles / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects*; D013390:Succinylcholine / Q000494:pharmacology*; D009435:Synaptic Transmission / Q000187:drug effects*; D014403:Tubocurarine / Q000494:pharmacology*
D002800:Cholinesterase Inhibitors; D003650:Decamethonium Compounds; D005730:Ganglionic Blockers; D013390:Succinylcholine; D005703:Gallamine Triethiodide; D014403:Tubocurarine